Pharmaceutical company
Aptcure (PVT.) Ltd
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
18products
12generics
2therapeutic areas
18current prices
Portfolio intelligence
Therapeutic mix
Unclassified 14Third-generation cephalosporins 2Fluoroquinolone antibacterials 2
Company portfolio
18 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Apt-Z | Zinc | 20 mg | Tablet | 3x10's | 103742 | PKR 205.93 |
| Apticip | Ciprofloxacin | 500 mg | Tablet | 1x10's | 053597 | PKR 397.77 |
| Apticip | Ciprofloxacin | 250 mg | Tablet | 1x10's | 053596 | PKR 240.53 |
| Apticlar | Clarithromycin | 500 mg | Tablet | 1x10's | 067866 | PKR 823.31 |
| Aptidopa | Levodopa + Carbidopa | 250 mg + 25 mg | Tablet | 10x10 | 060545 | PKR 1,407.73 |
| Azaltic | Azithromycin | 500 mg | Tablet | 1x6's | 106163 | PKR 393.26 |
| Azaltic | Azithromycin | 250 mg | Tablet | 1x6's | 074913 | PKR 282.98 |
| Bis-apt | Bisoprolol fumarate | 5 mg | Tablet | 20's | 103726 | PKR 178.75 |
| Bystxon | Ceftriaxone | 1 g | Injection | 1's | 087487 | PKR 593.88 |
| Bystxon | Ceftriaxone | 250 mg | IV injection | 1's | 085225 | PKR 186.86 |
| Bystxon | Ceftriaxone (as sodium) | 500 mg | IV injection | 1's | 085226 | PKR 314.53 |
| Cef-apt | Cefixime | 100 mg/5 mL | Suspension | 1's | 085229 | PKR 314.85 |
| Ferpol | Iron polymaltose complex + Folic acid | 0.35 mg + 0.35 mg | Tablet | 1x10's | 074912 | PKR 129.51 |
| Resapt | Risperidone | 2 mg | Tablet | 10's | 103731 | PKR 278.86 |
| Resapt | Risperidone | 3 mg | Tablet | 10's | 103732 | PKR 429.01 |
| Resapt | Risperidone | 1 mg | Tablet | 10's | 103730 | PKR 171.61 |
| Trebac | Levofloxacin | 500 mg | Tablet | 1x10's | 067863 | PKR 769.65 |
| Trebac | Levofloxacin | 250 mg | Tablet | 1x10's | 067864 | PKR 462.53 |